hg_45873.1

Basic information about the TSS

---

TSS ID: hg_45873.1 Species: human Chr: chr3		Start: 184243576 End: 184243589 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000485912.1 Distance: 0 GeneID: 10195 HGNC/MGI_ID: HGNC:23056 UniProt_ID:

Gene_name: ALG3 alpha-1,3- mannosyltransferase Gene_symbol: ALG3 Gene_synonyms: CDGS4 D16Ertd36e NOT56L Not56 Gene_source: HGNC:23056

TATA-Box annotation

---

Distance to TSS:	2178
Nearest PromoterID:	NR_030410
Entrez ID:	100187716
Nearest Unigene:
Nearest Refseq:	NR_030410
Nearest Ensembl:	ENSG00000221120
Gene Name:	ALG3 alpha-1,3- mannosyltransferase
Gene Alias:	MIRN1224|mir-1224
Gene Description:	microRNA 1224
Gene Type:	ncRNA
CpG%:	0.005
GC%:	0.502488
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ALG3 p2@ALG3 p3@ALG3 p4@ALG3 p5@ALG3 p7@ALG3
Sample		p1@ALG3	p2@ALG3	p3@ALG3	p4@ALG3	p5@ALG3	p7@ALG3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	56.69	7.21	1.56	7.01	1.56	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	60.49	5.46	2.23	5.66	1.82	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.38	7.33	2.70	6.56	1.74	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	59.88	8.73	2.91	9.36	2.08	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	65.69	6.52	1.57	4.05	2.70	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.63	8.53	2.52	9.11	2.33	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	77.57	8.06	4.36	10.24	3.92	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	65.40	6.06	3.15	10.66	2.66	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.81	5.98	3.42	9.83	3.63	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	53.91	10.43	5.80	13.33	5.22	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	51.74	9.70	4.04	22.23	2.83	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	61.80	6.10	3.66	15.45	2.03	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	27.08	0.32	0.97	0.16	1.45	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.33	1.50	1.20	0.30	1.80	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.61	1.76	0.22	0.00	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	21.88	1.01	0.25	0.00	0.75	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.21	0.87	1.75	0.22	1.75	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	20.67	1.69	0.84	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.86	2.13	1.07	0.00	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.97	1.20	0.45	0.30	1.35	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.19	0.80	0.67	0.27	1.34	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.24	0.52	0.69	0.17	1.73	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.49	0.90	0.90	0.78	1.55	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.51	1.46	0.73	0.49	2.18	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.41	0.77	0.52	1.03	1.29	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	0.63	0.00	0.63	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	0.55	0.55	1.10	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.65	1.41	0.71	0.24	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.68	0.65	0.81	0.48	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.17	0.72	0.54	0.36	1.09	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.35	1.05	0.42	0.21	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.01	0.59	0.98	0.20	0.98	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.06	0.21	0.63	0.00	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.42	0.66	0.66	0.00	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.69	0.75	1.12	0.19	1.31	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.10	1.53	1.53	0.38	0.96	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.30	0.20	1.43	0.61	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.38	1.61	1.21	0.00	1.21	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.77	0.81	0.54	0.27	1.35	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.08	1.20	0.48	0.48	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.70	1.41	0.71	0.47	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.11	1.17	1.02	0.15	0.88	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	20.03	1.05	0.21	0.00	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.52	0.52	0.35	0.00	1.05	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.28	1.00	0.60	0.20	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.22	1.40	0.23	0.00	1.40	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.79	0.00	1.20	0.00	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.92	0.89	1.19	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.06	0.96	0.72	0.48	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.84	0.61	0.81	0.20	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.69	1.02	1.23	0.00	0.20	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.58	1.11	1.33	0.44	1.11	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	25.55	1.77	1.06	1.06	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.83	1.33	1.66	0.00	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	2.52	0.00	0.00	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.34	0.46	0.92	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.87	0.97	0.00	0.00	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.80	1.28	1.61	0.00	2.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	1.89	2.20	0.31	0.94	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	0.00	2.12	0.71	2.82	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.36	0.56	2.24	0.56	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	16.72	1.59	1.59	0.00	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.50	1.02	1.02	0.34	0.34	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.02	1.30	0.65	0.32	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	2.48	0.00	0.71	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	21.94	1.46	0.98	0.98	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.25	0.99	1.49	1.49	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.09	1.41	0.94	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	26.83	0.00	0.00	0.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.58	0.31	1.24	0.93	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	22.01	0.61	0.61	0.92	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	51.95	3.80	3.17	1.11	1.90	0.79
Adipocyte - breast, donor2	11327-117E4	41.87	2.57	1.28	0.80	1.28	0.96
Adipocyte - omental, donor1	11473-119C6	59.42	2.67	4.20	1.91	2.42	0.64
Adipocyte - omental, donor2	11474-119C7	34.38	0.75	2.99	2.24	0.75	2.24
Adipocyte - omental, donor3	11475-119C8	28.47	1.67	1.67	2.34	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	63.80	2.55	1.91	2.55	1.91	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	48.38	1.10	3.30	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	73.16	4.06	2.26	3.16	1.81	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	53.70	3.30	1.39	0.70	2.43	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	39.90	1.96	2.35	0.98	2.35	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	31.14	1.80	3.35	0.26	1.54	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	49.62	3.35	2.51	0.28	1.39	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	1.18	0.00	0.59	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	33.86	3.06	0.88	0.40	1.21	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	27.43	0.32	0.65	0.65	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	3.20	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	29.49	5.01	1.11	1.11	2.78	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	30.78	0.83	0.83	1.25	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.39	2.51	0.25	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	24.87	1.64	0.65	0.98	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.49	2.13	0.91	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	61.88	1.10	3.09	1.55	1.77	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	74.59	1.43	1.08	5.74	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	1.20	0.00	1.20	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	42.10	1.62	2.34	0.90	1.26	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	1.67	3.35	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	33.08	1.23	0.41	0.62	1.44	0.00
Anulus Pulposus Cell, donor1	11248-116E6	31.58	1.37	1.03	0.34	1.26	0.00
Anulus Pulposus Cell, donor2	11463-119B5	19.10	0.73	0.98	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	34.15	1.35	0.00	0.45	1.35	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	36.90	1.30	1.74	2.17	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	2.14	0.00	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	27.80	2.99	0.60	1.49	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	2.53	2.53	2.53	5.06	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.32	3.30	0.00	0.66	3.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.27	2.27	1.95	1.30	1.95	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	37.38	1.94	1.94	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.29	2.38	2.38	3.56	1.78	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.00	1.88	0.75	1.51	1.88	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	2.18	2.18	2.18	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	2.51	1.25	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	40.20	2.14	2.47	1.98	1.65	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.31	2.26	1.21	1.66	1.66	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	33.75	1.07	1.61	2.14	2.68	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.58	1.51	0.94	2.08	1.32	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.68	2.14	0.80	1.07	1.87	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	0.98	2.93	1.95	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.68	1.66	2.49	0.66	1.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	1.20	3.60	2.40	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.02	1.89	2.40	1.03	1.37	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	31.55	0.97	1.46	1.46	1.94	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.60	2.66	1.52	0.38	1.90	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	2.42	1.21	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.78	0.57	1.14	0.00	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.07	2.78	0.64	0.64	3.21	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	1.03	1.81	0.77	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.72	0.94	2.35	1.41	2.35	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.15	0.32	0.64	1.61	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	0.71	2.14	1.43	2.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	31.00	0.58	1.17	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.41	2.11	0.30	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	1.19	1.19	2.38	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	36.62	1.53	1.02	0.51	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.56	3.82	2.80	1.02	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.96	1.27	1.91	2.54	2.54	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.78	1.73	0.43	0.00	1.73	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.06	1.27	1.69	1.27	1.06	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.84	2.03	1.45	0.58	1.16	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	0.00	0.94	1.89	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.16	1.53	2.71	1.36	0.85	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	2.11	0.00	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.52	0.86	1.72	1.72	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	0.00	1.80	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	35.72	1.46	0.73	1.46	4.37	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.90	1.38	1.61	2.53	1.61	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	0.00	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.75	1.53	2.80	0.25	2.03	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	31.59	2.06	0.83	2.27	2.68	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.15	3.06	2.14	0.92	2.14	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.46	0.96	1.43	3.35	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.60	2.00	0.67	1.77	2.66	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	0.00	1.53	1.53	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.80	1.11	1.66	1.11	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.72	1.59	1.32	2.12	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.53	0.36	2.54	1.45	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	33.53	1.47	1.60	0.86	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	39.88	1.37	0.86	1.03	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	29.99	1.26	0.42	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	21.26	0.00	0.70	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	25.40	0.81	0.97	0.16	0.97	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	28.49	0.30	0.45	0.30	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	51.61	3.67	1.15	3.10	1.03	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	53.75	3.88	1.00	2.13	1.50	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.23	3.64	1.48	1.93	1.25	0.34
Basophils, donor1	12241-129G9	17.26	0.00	0.78	0.78	0.78	0.00
Basophils, donor2	12242-129H1	17.68	0.36	0.72	0.36	0.00	0.00
Basophils, donor3	12243-129H2	23.96	0.15	0.44	0.29	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	40.96	2.16	1.51	1.72	1.51	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	59.43	1.37	1.83	0.46	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	53.35	0.63	2.51	5.02	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	47.20	1.04	3.33	3.12	2.08	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	33.85	0.92	0.46	2.99	0.92	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	45.17	1.26	1.62	1.08	0.72	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	49.78	1.75	2.99	4.33	2.58	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	76.39	1.16	4.66	5.36	2.33	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	54.68	3.84	2.56	1.92	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	17.47	0.00	0.56	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	15.59	0.19	0.56	0.00	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	20.42	0.22	0.66	0.00	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	50.66	1.70	1.13	0.57	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.94	1.52	0.00	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	35.18	1.97	0.33	0.66	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	7.95	0.29	0.29	0.14	0.58	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	7.54	0.30	0.30	0.00	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	8.53	0.24	0.71	0.00	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.68	0.17	0.00	0.33	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.69	1.10	0.00	0.28	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	0.50	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.87	0.00	0.20	0.20	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.99	0.36	0.53	0.00	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.31	0.44	0.44	0.22	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.32	0.00	0.47	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	0.00	0.45	0.00	0.15	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.99	0.00	0.20	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	0.21	0.21	0.21	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.63	0.46	0.00	0.00	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.71	0.00	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.11	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.46	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.47	0.35	0.00	0.00	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.57	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.94	0.18	0.18	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.93	0.70	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.63	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	0.17	0.00	0.00	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.58	0.00	0.00	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.33	0.43	0.22	0.00	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	0.00	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.48	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.25	0.23	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	27.90	0.22	0.87	0.00	0.44	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	27.72	0.23	1.15	0.46	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	30.54	0.43	1.95	0.22	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	43.60	1.09	0.78	0.62	0.93	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	31.26	0.52	0.17	0.35	1.05	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	34.34	0.67	0.45	0.22	0.67	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	30.62	0.00	0.51	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	25.03	0.44	0.22	0.00	0.88	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	26.53	0.63	0.84	0.21	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	1.36	0.68	0.00	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	36.25	1.04	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	46.91	3.20	2.67	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.67	0.54	1.07	0.00	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	1.40	0.00	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	46.28	0.00	1.57	0.00	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	39.55	2.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	21.37	1.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	0.00	1.45	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	18.17	0.00	0.50	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	31.52	4.85	1.62	2.02	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	29.56	2.80	0.40	3.20	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	15.06	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	7.30	0.00	1.12	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	77.41	2.63	0.75	2.25	2.63	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	60.43	5.19	1.35	2.48	1.35	0.00
CD4+ T Cells, donor1	11225-116C1	24.64	0.71	0.71	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	18.98	0.61	1.22	0.00	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	22.26	0.00	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	41.86	2.30	1.02	0.26	1.79	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	56.82	1.35	1.12	0.22	1.35	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	58.93	2.01	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	54.99	0.95	0.95	0.00	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	53.38	0.00	1.40	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	31.79	1.16	0.72	0.72	0.72	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.20	1.36	1.19	0.17	0.51	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.59	1.13	0.64	0.16	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	27.35	0.00	0.45	0.45	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.18	0.70	0.70	0.00	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.92	0.00	1.32	0.44	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.48	1.26	1.69	0.84	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.48	1.87	0.83	1.45	0.83	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.76	1.34	1.00	0.33	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	46.50	1.09	1.36	0.00	0.27	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	0.54	1.07	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	3.59	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	48.03	1.67	1.85	0.56	0.56	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	53.50	0.65	1.08	0.43	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	47.91	1.47	0.63	0.42	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.93	0.51	0.51	0.00	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.69	0.87	0.00	0.00	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.74	0.44	1.31	0.44	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	55.43	0.00	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	1.40	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	42.65	2.49	1.38	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	42.21	0.74	0.98	0.00	0.49	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.05	1.07	0.36	0.72	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	65.09	0.00	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	21.61	0.00	1.96	0.00	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	18.40	0.38	0.38	0.00	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	21.97	0.76	0.00	0.25	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.91	3.21	2.98	2.06	1.38	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.06	2.16	2.40	2.88	2.40	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	36.93	2.74	1.64	3.28	0.82	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	45.33	4.50	1.50	2.10	1.80	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.04	2.88	1.68	2.64	1.68	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.75	2.96	1.59	2.05	2.73	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	54.54	4.56	0.65	2.61	1.30	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.69	5.26	1.32	2.37	1.32	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	51.59	4.46	2.11	2.11	2.11	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	58.87	2.72	1.51	1.81	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	39.51	1.74	2.03	2.03	1.74	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	44.23	1.87	1.07	2.40	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.08	0.44	1.31	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.75	1.37	1.37	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	0.75	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	54.02	2.16	2.16	1.08	1.80	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	58.70	2.30	1.44	1.15	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	42.66	3.30	2.12	1.18	2.12	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	54.19	6.02	0.63	1.58	1.27	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	46.44	4.00	2.15	1.54	2.77	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	50.01	1.92	1.92	3.53	1.92	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	43.22	3.82	0.38	0.76	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	40.59	2.36	1.18	1.18	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	38.58	1.51	0.76	1.51	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	0.80	2.41	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	0.00	0.70	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	0.00	1.00	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	27.42	0.00	1.83	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	47.43	0.99	2.47	0.99	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	47.67	2.00	2.00	1.68	2.74	0.11
Chondrocyte - de diff, donor1	11261-116G1	39.87	1.73	0.69	0.69	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	30.21	2.84	0.71	0.00	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	26.97	1.93	1.82	0.34	1.37	0.00
Chondrocyte - re diff, donor2	11339-117F7	37.60	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.04	2.83	4.04	1.21	2.02	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	25.36	0.69	0.57	0.46	1.15	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	21.16	0.43	1.28	0.86	1.28	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	21.86	0.97	1.42	0.44	1.06	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	40.81	0.92	1.74	0.46	2.29	0.18
Corneal Epithelial Cells, donor1	11526-119I5	60.82	1.32	1.54	1.54	1.98	0.00
Corneal Epithelial Cells, donor2	11606-120I4	44.37	1.14	2.28	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	49.85	2.30	2.56	2.81	2.56	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.48	2.15	0.83	0.50	1.16	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	19.24	1.89	0.95	0.32	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	21.92	1.84	0.43	0.86	1.51	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.21	0.68	1.37	0.00	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	0.65	0.00	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.45	1.45	0.00	0.97	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	29.68	1.83	0.83	1.67	1.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	21.71	1.17	0.59	0.59	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	29.98	1.98	2.26	1.13	1.70	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	19.27	1.18	0.39	1.57	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	35.49	1.16	2.62	1.75	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	48.00	2.35	0.94	2.59	2.35	0.24
Endothelial Cells - Artery, donor3	11413-118E9	44.88	0.70	0.88	2.98	3.33	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.72	0.66	1.33	0.89	1.55	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	28.60	0.30	0.61	0.91	1.83	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.65	0.28	1.41	1.13	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	22.88	0.30	2.97	2.08	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	20.31	1.04	1.56	1.56	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.42	1.28	0.99	0.57	1.42	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	33.21	1.20	1.20	2.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	34.59	1.05	0.52	2.10	2.10	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.53	0.75	1.49	1.12	1.74	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.60	1.30	0.22	1.09	1.52	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.52	1.34	0.85	0.98	1.47	0.00
Endothelial Cells - Vein, donor1	11267-116G7	38.68	1.14	1.14	3.41	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	41.21	2.79	2.79	2.10	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.30	0.79	1.88	1.10	2.04	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	37.38	0.73	1.22	1.71	2.44	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	0.00	2.08	8.32	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.35	1.64	1.23	0.41	2.46	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.93	1.42	1.09	1.20	2.63	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.28	1.63	1.19	0.98	0.43	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.84	2.43	2.67	2.55	2.55	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.11	1.50	1.77	0.96	2.59	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.54	1.90	1.79	0.95	1.79	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	58.49	2.63	3.16	1.32	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.55	1.66	1.66	1.00	1.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	39.01	1.36	2.72	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	52.30	0.76	0.76	4.55	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	48.10	1.42	3.31	4.73	3.63	0.16
Fibroblast - Cardiac, donor4	11452-119A3	34.55	1.21	2.42	1.82	1.52	0.00
Fibroblast - Cardiac, donor5	11456-119A7	27.41	1.90	0.76	1.14	1.27	0.25
Fibroblast - Cardiac, donor6	11460-119B2	34.41	1.52	1.21	1.21	0.76	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	44.48	3.48	2.28	1.21	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.49	0.86	3.02	0.86	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	48.34	0.00	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	72.42	1.61	1.85	0.46	1.38	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	35.79	5.43	1.02	0.68	1.70	0.00
Fibroblast - Dermal, donor1	11269-116G9	53.76	2.35	1.88	2.58	1.17	0.47
Fibroblast - Dermal, donor2	11346-117G5	47.17	1.42	1.89	2.83	2.83	0.00
Fibroblast - Dermal, donor3	11418-118F5	58.51	1.57	0.73	0.85	2.42	0.36
Fibroblast - Dermal, donor4	11450-119A1	35.38	0.34	0.68	0.11	0.45	0.45
Fibroblast - Dermal, donor5	11454-119A5	35.94	1.05	0.87	1.05	0.87	0.35
Fibroblast - Dermal, donor6	11458-119A9	38.82	1.14	0.65	1.95	0.81	0.32
Fibroblast - Gingival, donor1	11237-116D4	41.44	1.87	1.04	1.04	2.50	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.20	0.79	0.79	1.05	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	42.83	1.19	0.66	0.40	1.19	0.40
Fibroblast - Gingival, donor3	11394-118C8	31.62	1.16	0.58	0.87	1.06	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.55	1.06	0.53	0.00	1.94	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.22	2.18	2.18	1.40	0.78	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	28.94	1.08	0.27	1.35	0.68	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.94	1.76	1.41	0.71	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.83	0.88	0.15	0.29	1.02	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	30.54	2.18	1.36	1.36	0.14	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.75	1.54	0.66	0.77	0.77	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.72	0.44	1.76	0.15	2.05	0.15
Fibroblast - Lung, donor1	11270-116H1	59.81	1.36	2.72	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	0.00	0.00	0.00	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	48.75	1.90	2.11	0.63	2.53	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	119.12	5.83	5.00	5.00	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	2.80	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	47.02	2.52	2.80	0.56	1.40	1.12
Fibroblast - Mammary, donor1	11540-120B1	105.96	3.25	4.06	3.65	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	91.87	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	0.00	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.51	0.97	0.39	0.78	1.16	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.02	1.67	0.30	1.52	0.61	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	54.77	2.75	1.22	0.92	1.84	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.57	0.00	1.14	0.38	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	30.24	1.62	1.35	0.81	1.62	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.25	1.62	0.93	0.81	1.51	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	48.86	3.21	1.66	3.21	1.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	75.18	3.66	1.42	1.63	2.84	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	66.82	1.34	2.00	1.34	2.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.14	2.77	1.58	1.19	1.58	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.93	1.98	1.59	0.99	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.51	1.07	0.53	0.89	1.60	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.24	2.17	0.59	0.59	1.77	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	76.12	1.50	3.01	2.71	2.11	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.02	2.05	1.08	1.08	0.54	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.85	1.27	0.76	0.25	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	28.39	2.79	1.15	0.98	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	69.17	1.40	2.21	1.20	1.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	24.31	1.41	1.71	1.00	0.60	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.43	0.91	1.81	0.30	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.45	1.91	0.50	0.58	1.16	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.47	1.54	1.20	0.51	0.68	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	50.25	1.31	2.96	0.66	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	26.42	1.17	1.07	1.07	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	37.78	1.69	0.84	1.35	1.01	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	20.70	2.82	0.94	0.63	0.47	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	0.00	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.99	0.87	1.21	1.56	1.39	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.23	2.86	2.60	2.34	2.60	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	29.13	0.26	2.04	0.51	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	42.87	2.30	4.59	1.53	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	51.68	2.55	5.10	3.19	6.38	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.35	2.00	5.13	6.28	2.85	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	36.12	0.28	1.93	1.10	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	33.11	1.60	2.05	0.68	1.83	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	47.15	3.96	7.13	2.77	3.57	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	31.72	0.79	1.32	0.00	1.06	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.51	0.65	2.28	0.00	0.98	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	42.90	6.19	7.52	4.42	2.21	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	55.68	2.12	5.37	3.67	2.12	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	46.42	1.11	5.54	3.20	3.20	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.20	2.15	9.13	3.49	1.88	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	43.49	0.50	2.35	1.12	1.61	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	47.62	0.69	2.77	2.21	1.38	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.98	1.02	6.71	3.46	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.49	0.68	2.51	2.28	1.14	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.62	1.00	2.24	1.12	1.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	42.19	0.87	2.84	2.40	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.73	1.77	3.25	0.59	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	38.15	0.79	2.86	1.27	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	49.15	1.12	2.23	0.89	1.34	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	51.21	1.01	1.41	1.21	1.41	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.05	1.19	1.53	1.87	1.53	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	51.43	1.77	4.26	3.90	1.68	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.81	2.50	2.91	2.29	1.87	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	80.78	2.22	2.90	1.88	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	45.92	1.22	2.55	1.11	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.33	2.25	3.16	1.58	1.58	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.23	1.43	3.06	1.84	1.63	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	49.72	1.24	1.03	1.24	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.08	1.27	1.73	0.46	2.31	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	57.70	1.83	2.00	2.00	1.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.23	1.54	1.98	0.66	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	52.03	0.98	0.74	1.35	2.34	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	50.25	1.78	1.78	2.11	2.92	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.27	2.57	1.60	0.64	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	49.75	1.33	1.52	0.95	1.23	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	61.85	1.90	1.42	1.11	1.90	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.44	1.22	1.52	1.22	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.97	1.36	1.36	1.25	1.36	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	65.65	1.98	2.20	1.10	1.76	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	56.95	1.40	0.84	1.96	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.85	0.93	0.93	1.85	1.67	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	55.09	1.87	2.67	2.67	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	55.85	2.30	2.60	2.91	1.07	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	49.09	1.81	1.04	1.81	2.85	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	51.77	1.08	1.63	0.81	1.36	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	48.30	1.29	2.03	0.74	1.29	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	51.98	1.32	1.54	0.66	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	87.27	0.00	0.99	0.99	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.79	2.24	1.71	0.92	1.32	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	49.63	1.41	1.61	0.81	2.02	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	111.32	3.30	7.12	2.29	4.57	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	47.77	2.99	11.55	6.37	0.40	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	60.24	1.39	7.86	4.31	2.47	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	54.21	3.48	8.39	4.71	2.86	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	58.83	2.19	10.33	3.76	2.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.55	2.26	14.69	5.37	4.80	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.89	1.84	9.69	3.69	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	4.95	4.95	12.37	9.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	56.47	0.77	8.12	4.64	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	65.78	3.21	11.23	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	5.22	6.96	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	38.08	2.60	6.51	0.65	2.60	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.42	1.65	5.77	4.12	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	3.33	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	41.39	1.96	5.03	3.64	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	37.26	1.63	7.84	4.25	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	1.68	2.52	0.00	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	44.85	2.86	5.41	0.64	0.95	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.93	3.06	4.42	2.38	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	46.96	1.15	6.30	1.15	1.72	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	50.02	2.37	5.03	1.78	2.37	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	0.00	10.16	0.00	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	41.83	3.73	5.80	2.07	2.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	42.34	1.38	3.45	0.92	2.07	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	5.27	10.54	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.14	1.54	5.38	1.92	1.92	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.60	0.98	4.89	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.75	3.34	4.01	2.01	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.46	1.54	5.01	1.16	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	41.42	0.68	6.85	1.71	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	47.19	1.42	1.89	0.00	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	33.80	1.21	1.81	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	1.02	2.03	0.51	3.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	45.07	2.39	3.59	1.60	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.67	2.47	1.97	0.00	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	60.20	1.18	3.54	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	50.76	1.75	2.92	0.58	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.90	1.76	3.07	1.32	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	28.82	0.85	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	21.49	2.39	1.79	0.00	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.54	2.91	4.37	0.97	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	57.07	5.71	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.09	1.66	1.66	1.25	2.49	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	65.22	1.12	1.12	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	0.63	0.95	0.32	1.59	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.32	2.09	0.84	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	100.96	2.90	4.76	5.45	4.41	2.20
Hep-2 cells mock treated, biol_rep2	11899-125E9	104.49	4.05	4.90	4.05	4.56	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	96.23	2.28	3.19	4.32	3.87	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	105.81	3.06	4.81	3.61	6.34	3.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	109.39	3.65	3.44	4.94	5.59	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	107.86	3.01	5.81	4.52	5.38	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	104.11	4.73	4.61	3.11	4.86	2.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	91.26	4.29	2.40	2.74	3.77	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	90.67	2.24	5.45	2.56	4.49	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.62	0.00	1.12	0.56	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.91	1.73	3.03	1.30	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	40.56	1.41	2.12	0.35	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	49.40	3.63	2.18	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	50.00	2.45	4.02	4.37	1.05	0.17
Hepatocyte, donor1	11523-119I2	82.32	3.63	3.63	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	82.95	1.08	1.08	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	73.01	1.84	0.61	0.61	3.07	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.91	4.57	2.61	3.26	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	87.92	7.34	11.01	4.37	4.72	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.83	2.06	1.23	1.92	1.65	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	206.95	9.55	6.37	9.55	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	300.39	13.35	13.35	13.35	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	216.67	27.08	0.00	27.08	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	231.19	5.54	1.38	13.84	5.54	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	265.28	15.02	5.01	22.52	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	213.63	0.00	0.00	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	246.04	7.69	5.13	25.63	7.69	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	310.81	9.14	0.00	13.71	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	321.62	11.37	9.75	19.49	9.75	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	181.74	15.01	1.67	21.67	5.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	250.51	14.52	3.63	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	301.75	10.59	6.62	25.15	7.94	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	181.82	7.76	2.22	15.52	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	225.25	15.71	0.00	26.19	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	195.89	5.04	4.41	17.01	9.45	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	179.41	9.28	1.55	12.37	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	238.39	9.04	4.52	17.44	7.11	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	260.81	12.88	3.22	19.32	6.44	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	179.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	255.06	8.96	5.70	24.45	6.52	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	251.89	13.01	6.30	23.93	5.88	5.04
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	0.00	0.00	0.00	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	208.96	11.25	6.43	14.47	4.82	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	178.19	5.54	4.62	13.85	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	185.51	5.19	6.61	10.38	4.25	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	164.16	3.63	2.72	8.16	2.72	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	217.38	7.53	1.08	17.22	5.38	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	265.53	3.81	7.62	22.87	8.89	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	230.03	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	246.14	8.29	6.38	22.32	6.38	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	236.95	3.65	12.76	20.05	3.65	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	237.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	226.36	7.14	2.86	22.14	7.14	5.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	215.69	9.95	3.32	9.95	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	208.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	162.97	4.01	3.09	14.20	5.25	2.16
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	265.16	14.05	3.51	19.32	7.02	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	257.74	9.43	0.00	12.57	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	181.50	8.34	4.87	16.69	3.48	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	402.78	26.56	2.21	15.49	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	330.69	6.48	3.24	16.21	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	287.74	6.10	12.21	14.82	6.98	6.98
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	337.47	9.00	9.00	11.25	11.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	355.43	17.42	6.97	27.88	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	301.90	11.73	4.27	12.80	13.87	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	320.04	11.08	4.16	18.01	6.93	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	336.25	14.25	2.85	37.04	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	266.00	17.49	9.20	25.77	7.36	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	242.03	9.08	6.05	12.10	6.05	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	322.85	12.42	6.21	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	281.26	10.57	4.23	15.86	3.17	2.11
Keratinocyte - epidermal, donor1	11272-116H3	49.29	2.20	4.32	5.79	3.43	0.65
Keratinocyte - epidermal, donor2	11349-117G8	41.58	1.76	0.59	2.34	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	48.18	1.04	1.14	3.22	1.42	0.47
Keratinocyte - oral, donor1	11251-116E9	58.35	1.25	0.91	2.38	2.50	0.34
Keratocytes, donor1	11527-119I6	74.96	3.78	1.03	2.06	1.72	0.34
Keratocytes, donor2	11607-120I5	46.87	2.34	2.34	0.00	2.34	1.17
Keratocytes, donor3	11688-122I5	43.08	3.75	0.40	1.98	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	28.05	1.08	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.18	0.81	0.81	0.00	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	27.45	1.82	2.52	1.41	1.72	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.08	2.02	0.71	2.49	1.07	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	26.79	0.84	1.12	3.35	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	24.40	2.05	1.42	2.52	1.26	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.42	1.08	1.61	3.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.21	1.89	0.95	1.26	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.58	1.94	0.86	2.48	0.97	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.75	2.05	0.82	1.23	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.28	2.02	0.76	1.26	2.02	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.24	1.41	1.55	2.39	1.41	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	0.79	0.79	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.88	1.16	0.97	1.36	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	23.51	1.67	0.56	1.67	1.67	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	20.21	1.39	0.70	1.74	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.05	2.15	1.19	2.39	1.43	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.27	1.65	0.96	2.33	1.37	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	1.85	0.00	0.92	2.16	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.37	1.25	0.94	3.12	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	28.55	1.83	1.28	2.93	1.10	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	0.99	0.33	2.63	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	27.53	2.93	1.17	2.93	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.12	1.99	2.49	4.48	1.74	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.76	0.48	0.48	1.94	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.35	1.62	0.81	1.62	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.31	1.67	1.67	2.27	1.21	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.77	0.52	1.04	3.63	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	22.82	2.30	1.26	2.09	1.68	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.02	1.20	1.20	2.56	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.76	3.44	0.69	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.88	0.56	0.75	1.32	1.13	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.73	1.27	1.70	1.59	1.38	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	22.78	0.00	0.00	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.17	1.32	1.32	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.17	1.24	0.99	2.35	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.51	1.48	1.11	2.96	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.72	0.74	0.49	0.49	1.48	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.24	1.92	1.10	1.24	0.96	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.41	0.96	0.96	0.96	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	25.87	0.61	1.52	0.91	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.11	0.98	1.12	1.54	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.76	0.71	0.71	0.71	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	29.57	0.48	1.94	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.05	1.09	1.24	3.27	1.71	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.01	2.15	0.36	1.43	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.75	0.33	1.31	0.98	1.63	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.43	1.65	1.88	2.83	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	32.79	1.86	3.34	1.98	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.59	0.51	1.79	1.54	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	31.63	1.79	1.49	1.19	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	6.80	4.53	0.00	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	63.67	6.14	3.84	2.30	4.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	53.44	4.45	5.20	0.74	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	51.62	8.46	9.31	1.27	3.81	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	50.64	5.63	5.63	2.11	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	70.98	7.47	4.67	1.87	5.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.34	5.67	6.18	2.58	4.12	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	54.72	7.14	5.95	2.38	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	54.06	5.20	7.24	2.04	6.56	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.32	3.20	4.65	3.20	5.82	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.72	4.95	2.70	0.90	4.05	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.94	6.91	7.72	2.03	5.96	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	50.33	6.68	5.65	1.54	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	34.23	3.53	5.29	3.18	3.18	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.31	3.33	6.00	2.00	5.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	53.99	5.09	5.60	1.53	6.11	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.62	4.80	5.34	2.13	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.22	2.83	6.24	1.89	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	7.36	3.68	1.84	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	52.19	6.52	1.63	2.45	5.71	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	38.73	3.12	4.79	1.46	3.54	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.24	3.92	4.48	0.84	2.24	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	58.73	5.15	6.18	2.06	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	39.77	3.19	2.61	2.61	2.03	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	44.24	3.59	5.38	2.39	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	29.88	3.32	3.32	1.66	2.77	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	51.61	5.30	8.48	2.12	4.60	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	46.47	5.53	2.58	1.48	2.58	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	13.82	4.61	3.45	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	59.87	4.61	6.91	2.69	4.22	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	52.65	7.36	5.66	1.13	5.10	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.87	4.92	7.38	1.64	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	56.49	6.78	8.59	1.36	6.33	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	46.68	8.62	7.18	4.31	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	58.26	6.72	5.23	3.73	5.98	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	50.91	5.95	3.72	4.46	3.34	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.04	2.15	5.17	3.02	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	56.52	5.14	8.56	0.00	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	65.30	5.00	4.66	1.67	6.33	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.09	3.62	6.03	1.81	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	60.43	6.40	7.82	2.13	3.55	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	55.68	4.81	7.91	1.03	3.44	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	54.21	4.83	4.83	2.15	3.76	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	66.66	4.04	6.73	1.35	5.39	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	55.93	4.07	6.67	1.11	6.30	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	3.49	12.79	5.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	57.12	11.64	8.46	4.23	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	55.62	1.60	7.20	2.00	4.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	55.97	5.81	6.54	3.63	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	70.52	5.37	7.67	0.77	3.83	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	56.23	7.40	4.44	2.96	6.41	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	58.34	0.00	11.29	2.82	3.76	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	62.35	9.55	7.54	3.02	5.53	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	5.86	7.21	3.15	4.06	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	6.88	8.61	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	60.57	5.79	4.01	2.67	5.79	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	55.53	8.60	8.21	3.13	2.74	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.92	4.62	5.28	3.30	5.94	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	50.85	7.78	4.67	2.08	4.67	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	56.45	4.81	6.13	2.19	1.75	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	34.66	3.35	7.83	1.12	5.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	58.30	4.86	9.72	2.65	5.30	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.30	4.63	7.33	2.70	2.70	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	36.96	5.57	6.08	2.03	2.53	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	42.78	5.77	8.65	1.92	4.33	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	51.68	5.96	6.36	1.19	4.37	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	43.14	7.29	3.65	1.82	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	37.35	4.84	8.30	1.38	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	41.04	7.60	6.46	3.42	3.80	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	34.60	3.10	8.26	3.10	2.58	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.60	6.65	7.26	2.42	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.07	5.07	6.34	3.17	4.12	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	48.51	5.33	11.19	0.53	7.46	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	47.70	8.05	4.60	3.45	1.15	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.31	3.60	6.17	2.57	3.60	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	53.76	2.83	8.49	1.41	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	57.88	5.67	6.24	0.57	1.70	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	46.18	2.50	7.07	4.16	4.99	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	57.16	2.35	10.18	0.78	3.92	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.29	6.68	7.52	3.76	2.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	63.19	4.18	6.97	0.93	8.36	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	66.24	2.68	9.37	5.35	5.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	59.88	4.28	6.42	3.74	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	63.85	4.85	6.87	3.23	5.25	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	41.30	7.34	4.59	1.84	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	78.24	5.33	7.11	2.67	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	64.40	1.14	10.26	1.14	5.70	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	5.37	9.97	2.30	2.30	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.40	10.40	10.94	1.64	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	72.61	5.35	4.01	2.67	4.01	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	81.63	6.24	9.10	2.60	7.80	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	70.29	3.98	7.29	1.99	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	78.99	2.08	12.47	2.08	10.39	2.08
Macrophage - monocyte derived, donor1	11232-116C8	42.39	1.14	0.46	0.68	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	40.74	2.02	0.92	1.10	0.92	0.18
Macrophage - monocyte derived, donor3	11389-118C3	46.80	1.44	1.18	0.92	1.57	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.86	1.59	2.12	3.72	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	24.88	1.58	1.27	1.58	0.63	0.16
Mallassez-derived cells, donor3	11930-125I4	30.86	1.39	0.83	2.50	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	44.54	1.59	2.59	5.28	1.89	0.10
Mammary Epithelial Cell, donor2	11350-117G9	43.14	1.45	1.74	2.61	1.45	0.29
Mammary Epithelial Cell, donor3	11422-118F9	47.14	2.49	1.50	1.50	2.74	0.00
Mast cell - stimulated, donor1	11487-119E2	23.73	1.36	2.03	1.36	1.36	0.00
Mast cell, donor1	11563-120D6	24.76	1.08	1.08	0.65	0.22	0.00
Mast cell, donor2	11565-120D8	19.91	0.59	1.49	0.00	0.59	0.30
Mast cell, donor3	11566-120D9	26.56	0.45	0.45	0.00	0.45	0.00
Mast cell, donor4	11567-120E1	18.08	0.00	0.35	0.35	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	81.95	2.66	2.11	1.11	0.78	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	38.52	4.67	3.50	2.92	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	43.94	0.57	0.80	0.00	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	33.64	1.00	1.00	0.33	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	40.60	2.09	1.59	1.09	1.49	0.10
Melanocyte - dark, donor2	11582-120F7	42.91	2.08	2.08	1.38	2.77	0.00
Melanocyte - dark, donor3	11663-122F7	88.81	2.17	2.54	1.67	1.96	0.00
Melanocyte - light, donor1	11274-116H5	70.29	3.29	1.41	0.94	1.41	0.24
Melanocyte - light, donor2	11351-117H1	67.56	1.36	4.09	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	52.90	1.73	0.87	0.87	4.34	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	89.65	2.71	1.25	1.56	3.33	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	67.77	0.27	1.34	1.34	3.77	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	61.61	0.80	1.61	0.00	1.87	0.54
Meningeal Cells, donor1	11493-119E8	71.09	4.34	1.61	2.48	0.50	0.25
Meningeal Cells, donor2	11573-120E7	60.30	3.52	1.32	1.76	1.76	0.44
Meningeal Cells, donor3	11654-122E7	70.25	3.67	1.55	2.85	1.71	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.51	1.14	0.57	0.57	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.24	3.62	2.72	1.91	1.81	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	98.56	3.94	1.31	0.00	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	68.02	0.00	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	80.37	0.72	3.59	3.59	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.41	1.27	0.85	0.64	1.48	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.12	1.01	3.02	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	70.32	3.08	1.76	0.66	1.10	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	48.22	0.73	2.19	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	59.54	2.05	0.82	0.82	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.13	1.66	1.11	0.69	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	66.54	0.74	2.97	2.60	2.60	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	45.26	1.97	1.71	0.92	1.58	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	55.79	4.15	5.34	1.19	3.56	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	72.40	0.00	0.00	2.34	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	47.39	2.56	3.20	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	79.04	1.77	2.84	1.77	3.54	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	38.78	1.88	0.94	0.31	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.23	3.63	4.35	5.81	4.35	0.00
Mesothelial Cells, donor1	11247-116E5	53.04	3.18	2.39	0.80	3.18	0.27
Mesothelial Cells, donor2	12156-128G5	38.54	4.00	2.00	3.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	38.30	1.66	1.01	1.23	3.61	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	34.97	1.97	0.49	1.23	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	28.27	0.59	0.88	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.35	2.17	0.00	1.24	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.32	1.04	0.00	1.87	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.03	2.25	0.00	0.25	1.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	0.93	0.47	1.86	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.11	1.22	0.41	0.00	0.41	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.05	3.17	0.00	1.58	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	0.88	0.88	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.13	3.04	0.38	2.28	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	28.01	1.70	0.85	0.00	0.21	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.78	0.30	0.30	1.79	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.08	1.00	0.50	1.00	0.75	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.34	1.19	0.48	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	0.55	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	29.70	2.99	0.46	0.46	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.35	0.42	0.00	0.63	0.84	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.33	0.61	0.20	0.61	0.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.53	0.43	0.21	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.90	0.67	0.67	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.12	1.53	0.22	1.10	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	14.19	2.03	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.75	0.27	0.82	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	29.11	1.76	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.83	1.92	0.48	0.96	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.01	1.20	0.40	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	1.00	0.00	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	2.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.55	1.24	0.25	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	0.70	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.22	1.03	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.75	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.81	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.97	2.24	0.84	0.56	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.63	0.83	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	17.80	1.51	0.30	1.21	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.11	1.25	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.95	2.28	0.57	1.71	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.68	1.24	0.00	0.69	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	26.69	1.30	0.00	1.55	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.45	0.86	0.00	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	0.64	0.00	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.61	0.53	0.00	0.53	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.45	2.10	0.30	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.58	0.71	0.57	0.71	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.66	2.23	0.64	2.87	0.64	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.90	1.77	0.66	1.11	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	0.38	0.00	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.00	2.56	0.28	0.57	0.57	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.81	0.74	1.23	0.98	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.00	0.65	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	20.58	0.88	0.59	1.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	23.64	0.86	0.86	2.02	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	0.00	0.82	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.06	0.60	1.19	0.60	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	86.64	3.77	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	71.63	1.31	0.99	1.97	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	56.81	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.92	2.97	0.20	0.40	0.20	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	3.73	0.93	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.19	1.50	1.50	0.38	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	45.54	1.86	0.27	0.27	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	36.76	1.02	0.34	0.68	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	2.95	0.00	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.53	1.47	0.73	0.73	1.47	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	56.00	0.00	0.00	4.67	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	1.60	0.53	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	60.60	1.01	1.01	3.03	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.94	1.26	0.00	1.69	0.84	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	0.00	0.00	5.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	9.54	1.91	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	22.68	1.62	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	9.50	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.10	2.37	0.86	2.59	2.15	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.13	2.61	0.00	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	0.67	0.67	0.00	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.70	0.83	1.67	0.42	2.50	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	21.11	0.95	0.76	0.76	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	0.00	0.68	0.00	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.07	0.00	2.09	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.31	0.46	0.23	0.46	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.27	0.81	1.35	0.00	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.27	1.47	0.21	0.00	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	1.49	1.49	0.00	2.48	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.78	0.27	0.81	0.00	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.81	1.36	1.13	0.23	1.13	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.68	0.82	0.98	0.00	0.98	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.59	1.09	1.09	0.00	0.55	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	0.53	0.53	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	0.60	0.00	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.86	0.66	0.66	0.33	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.34	0.16	0.65	0.16	0.98	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.63	1.06	1.23	0.53	0.53	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	0.00	2.11	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.71	0.92	0.92	0.00	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	1.29	0.96	0.32	0.96	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.49	2.07	0.34	0.69	0.69	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	2.53	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.94	0.22	0.67	0.89	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.32	0.42	0.42	0.85	1.69	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.19	0.71	1.66	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	1.72	2.58	0.00	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.66	0.67	0.67	0.00	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.94	0.90	2.25	0.00	1.80	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	0.79	1.19	0.79	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	0.93	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.16	0.76	1.14	1.14	3.41	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.69	0.65	0.65	0.00	1.96	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	18.30	0.00	0.44	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.35	0.90	0.90	0.00	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	2.65	1.76	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	0.00	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	0.00	0.00	0.50	1.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.78	1.91	0.77	0.38	1.91	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.66	1.81	0.60	0.60	1.81	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.33	2.43	1.55	0.66	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	4.74	2.03	0.00	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	0.61	1.22	0.00	3.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.16	0.63	0.31	0.31	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.46	0.61	0.61	0.00	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	1.58	0.00	0.00	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	0.00	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	37.27	2.24	2.36	1.99	1.49	0.50
Myoblast, donor2	11322-117D8	46.60	2.11	1.53	0.58	3.26	0.96
Myoblast, donor3	11398-118D3	35.48	1.18	2.52	0.34	1.85	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	54.72	3.65	1.61	1.46	1.75	0.29
Natural Killer Cells, donor1	11230-116C6	21.83	0.62	0.62	0.00	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	14.17	0.30	0.00	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	19.51	0.74	0.37	0.00	1.47	0.37
Neural stem cells, donor1	11275-116H6	38.11	0.73	3.27	1.09	0.73	0.36
Neural stem cells, donor2	11352-117H2	28.88	1.93	1.93	0.00	1.93	0.00
Neurons, donor1	11494-119E9	31.86	0.00	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	22.46	0.88	0.22	0.22	0.66	0.66
Neurons, donor3	11655-122E8	23.02	0.82	2.47	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	34.08	1.42	2.37	0.36	1.90	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	29.63	0.65	0.98	0.65	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	26.87	1.80	0.60	0.80	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	25.33	1.38	1.38	0.55	0.83	0.41
Olfactory epithelial cells, donor2	11934-125I8	24.17	1.88	1.01	0.87	1.74	1.01
Olfactory epithelial cells, donor3	11935-125I9	23.84	1.93	1.02	1.14	1.14	0.00
Olfactory epithelial cells, donor4	11936-126A1	29.32	1.27	0.97	0.78	0.49	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	0.60	0.60	1.81	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	20.84	3.19	0.85	0.43	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	44.58	3.43	1.14	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	37.24	0.62	0.00	1.86	1.24	0.00
Osteoblast, donor1	11277-116H8	50.62	2.35	2.35	2.74	1.95	0.00
Osteoblast, donor2	11354-117H4	51.27	2.11	2.11	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	31.99	1.42	1.24	0.89	1.60	0.18
Pancreatic stromal cells, donor1	11249-116E7	32.94	2.11	1.01	0.42	1.77	0.25
Pericytes, donor1	11491-119E6	43.17	2.11	1.45	1.11	0.89	0.11
Pericytes, donor2	11571-120E5	33.50	0.91	1.36	0.68	0.91	0.00
Pericytes, donor3	11652-122E5	49.03	2.44	2.24	2.24	3.66	0.41
Perineurial Cells, donor1	11499-119F5	43.51	2.15	1.47	0.45	1.58	0.11
Perineurial Cells, donor2	11579-120F4	47.94	3.13	2.76	1.84	1.56	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	31.56	0.00	0.00	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.79	0.00	0.49	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.93	0.26	0.78	0.00	0.52	0.13
Placental Epithelial Cells, donor1	11278-116H9	118.63	4.07	10.76	1.91	6.22	0.96
Placental Epithelial Cells, donor2	11355-117H5	73.19	0.00	6.65	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	39.27	4.12	4.71	1.77	1.77	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	43.35	2.22	1.90	1.58	1.90	2.53
Preadipocyte - breast, donor1	11467-119B9	34.89	3.75	3.38	2.06	1.31	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.89	1.57	1.44	0.65	1.31	0.00
Preadipocyte - breast, donor2	11328-117E5	34.90	2.93	2.93	1.58	1.80	0.90
Preadipocyte - omental, donor1	11468-119C1	36.12	3.09	3.20	1.70	2.66	0.21
Preadipocyte - omental, donor2	11329-117E6	33.61	1.31	1.75	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	44.69	2.72	3.87	3.01	3.58	0.43
Preadipocyte - perirenal, donor1	11469-119C2	26.58	1.97	5.91	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	77.09	3.38	3.38	1.84	3.07	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	61.27	2.12	2.83	1.77	2.66	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	51.77	2.38	2.04	1.36	3.07	0.34
Preadipocyte - visceral, donor1	11280-116I2	55.05	1.49	2.61	0.93	2.14	0.19
Preadipocyte - visceral, donor2	11357-117H7	47.40	0.92	2.30	2.30	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	36.05	1.15	0.94	0.94	0.63	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	76.78	6.03	11.92	2.87	6.94	0.15
Prostate Epithelial Cells, donor2	11331-117E8	24.37	0.81	2.71	2.44	2.03	0.81
Prostate Epithelial Cells, donor3	11404-118D9	37.17	1.84	0.43	1.84	1.04	0.24
Prostate Stromal Cells, donor1	11254-116F3	54.33	3.30	1.94	4.10	3.08	0.46
Prostate Stromal Cells, donor2	11332-117E9	49.31	3.23	0.90	1.97	1.97	2.69
Prostate Stromal Cells, donor3	11405-118E1	29.30	2.50	0.52	0.83	2.82	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	48.18	1.46	0.73	2.19	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.53	0.62	0.28	0.49	0.62	0.07
Renal Epithelial Cells, donor1	11517-119H5	62.90	3.04	0.51	2.03	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	39.83	0.71	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	37.69	0.32	1.06	0.64	0.64	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	30.64	0.00	2.04	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.01	1.21	0.54	1.62	0.54	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.08	0.67	0.67	0.89	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	59.89	0.00	2.00	1.33	4.66	1.33
Renal Mesangial Cells, donor1	11518-119H6	44.24	1.32	1.10	1.32	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	38.87	0.00	0.63	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	29.96	1.11	0.55	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	67.37	0.54	1.88	1.34	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	42.17	1.27	0.00	0.42	2.53	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	34.71	1.54	0.39	0.19	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	36.56	0.52	1.04	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.14	2.27	1.14	0.85	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	55.57	4.12	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	46.67	3.26	0.50	1.76	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	45.57	2.00	1.47	0.27	0.94	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	16.51	3.30	0.55	0.00	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	0.58	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.36	0.78	0.65	1.30	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.45	1.29	0.70	1.79	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.67	1.45	0.89	2.01	1.12	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.30	1.86	0.87	1.74	0.50	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.02	1.63	0.47	1.40	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.27	1.39	0.69	1.39	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.49	1.10	0.55	1.23	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	22.24	1.82	0.61	0.91	0.61	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.24	0.90	1.25	1.08	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.10	1.29	1.00	1.15	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.18	1.50	0.54	0.75	1.29	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.34	1.99	1.33	2.43	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	21.79	1.15	0.57	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.71	0.93	0.93	1.40	0.56	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	25.74	1.69	2.07	2.07	0.94	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	19.51	0.93	0.66	0.66	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.71	1.46	0.88	2.04	1.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.16	1.91	1.15	2.10	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	20.08	1.17	0.64	1.28	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.02	1.12	0.84	1.96	1.96	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.36	1.37	1.03	1.88	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	17.87	1.82	0.36	1.09	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.79	1.47	0.61	2.45	0.61	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	30.09	1.07	1.21	2.55	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.97	1.42	0.47	2.83	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.37	0.60	1.39	1.39	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.42	1.64	0.94	3.51	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.33	1.45	0.62	1.66	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.69	1.99	1.77	1.55	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.95	2.09	1.67	1.46	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.51	1.21	0.94	1.08	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.46	1.36	0.85	2.21	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	28.15	1.54	0.58	1.54	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.75	1.72	0.69	2.24	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	17.97	1.65	0.82	1.10	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.28	2.13	1.15	2.79	1.15	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.79	0.34	0.17	1.19	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.60	1.18	1.33	0.89	1.04	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.72	1.33	0.80	1.33	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.95	0.69	0.69	0.14	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.05	0.24	0.71	1.67	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	35.47	1.01	0.81	0.81	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.75	1.13	0.57	1.41	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.36	1.40	1.40	1.05	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.83	1.21	0.60	0.00	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	26.68	0.98	0.49	0.98	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.92	1.46	1.02	1.02	1.16	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.38	2.43	1.83	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	20.19	1.21	0.30	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.87	1.81	0.68	0.68	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	27.26	3.59	1.50	2.10	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.43	2.48	1.18	1.30	0.83	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	1.07	0.43	1.49	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	20.43	3.00	0.00	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	43.63	0.94	0.94	1.13	0.19	0.19
Schwann Cells, donor2	11578-120F3	47.63	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	50.39	1.53	1.10	0.66	0.66	0.44
Sebocyte, donor1	11220-116B5	92.03	4.38	7.12	6.03	7.67	0.55
Sebocyte, donor2	11301-117B5	52.85	2.30	2.76	3.68	2.76	0.00
Sebocyte, donor3	11378-118B1	62.86	2.68	2.68	3.50	4.33	0.82
Sertoli Cells, donor1	11255-116F4	39.76	1.66	0.00	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	33.89	2.82	2.82	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	52.08	3.87	1.85	2.02	1.67	0.35
Skeletal Muscle Cells, donor2	11358-117H8	41.92	2.89	0.00	0.00	3.61	0.00
Skeletal Muscle Cells, donor3	11430-118G8	88.62	1.67	5.85	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	40.06	1.41	1.57	1.10	1.89	0.94
Skeletal Muscle Cells, donor5	11455-119A6	37.01	1.49	1.34	0.89	0.74	0.89
Skeletal Muscle Cells, donor6	11459-119B1	43.09	0.62	0.62	1.23	0.92	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	38.18	1.51	2.27	0.88	1.13	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.96	1.28	1.85	1.14	1.00	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	54.76	1.19	1.29	1.39	3.08	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	41.70	5.39	2.11	2.70	2.53	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	37.64	0.72	1.45	0.00	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	27.79	0.96	0.96	1.10	1.10	0.69
Skin - palm, donor1	10286-104F7	13.43	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.40	0.58	1.73	2.59	1.30	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	2.45	0.82	4.91	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.02	1.56	3.38	1.95	1.30	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	26.41	2.09	2.50	2.78	1.67	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	21.10	0.28	0.42	1.13	1.13	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	53.28	2.96	3.81	2.11	2.75	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	24.13	1.35	0.82	1.05	1.05	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.14	1.54	1.23	1.85	1.54	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	64.92	2.89	3.78	1.11	1.78	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	57.02	1.76	2.35	0.59	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	55.69	3.09	3.09	3.31	3.09	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	39.77	2.36	1.58	3.15	2.36	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	6.95	1.55	0.00	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	1.00	2.00	2.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.38	1.73	2.53	3.99	2.26	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.89	2.44	1.55	1.11	2.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.16	1.79	0.64	2.30	0.64	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	1.63	0.98	0.65	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.46	1.77	1.77	0.89	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.46	1.42	1.42	0.71	3.42	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	69.62	2.28	2.11	2.11	2.28	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.35	0.91	0.61	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	59.35	3.28	2.27	1.26	2.02	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	0.00	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.67	1.43	2.38	1.43	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.73	1.77	1.03	0.88	1.62	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.49	2.58	1.08	1.08	1.94	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.30	2.41	1.68	1.05	2.20	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	45.48	2.17	1.08	4.33	1.70	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	48.50	1.08	6.47	4.31	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.47	0.90	3.29	0.90	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	64.87	2.05	3.41	2.73	2.39	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.61	2.04	1.65	0.24	1.10	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	34.72	1.71	2.52	1.01	1.31	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	45.51	3.19	2.73	5.23	2.73	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	45.89	3.62	1.81	4.83	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	72.59	3.71	3.18	1.85	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.62	3.33	1.33	1.07	0.80	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.94	2.88	1.38	1.88	3.13	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.41	1.01	0.76	0.51	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.60	2.56	0.60	1.66	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	48.76	0.00	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	2.58	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	80.92	6.05	4.65	2.79	3.72	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	46.95	1.51	5.05	2.52	2.52	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	39.17	2.82	3.45	1.88	1.57	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	40.41	2.95	1.18	1.77	2.06	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	58.65	1.75	2.92	1.92	1.75	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	0.93	0.00	0.00	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.24	1.58	1.30	4.61	2.45	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	49.97	2.55	2.04	4.84	2.04	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.53	1.88	1.50	1.50	0.94	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.63	2.38	1.12	1.26	0.56	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	46.84	2.77	1.84	2.26	2.51	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	132.38	4.76	2.38	2.38	3.33	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.14	1.96	2.45	2.20	1.96	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.73	2.21	1.77	1.10	1.55	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	37.16	2.93	0.29	0.59	1.76	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	21.38	1.75	1.36	0.19	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.45	1.85	0.53	1.06	0.53	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.16	1.86	1.49	1.12	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.90	3.23	1.08	0.36	1.08	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	33.22	1.70	0.85	1.14	1.70	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	35.05	1.97	1.18	1.58	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	25.40	0.51	1.02	0.51	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	1.20	0.00	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	0.42	0.42	1.25	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	27.96	2.29	1.38	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	29.12	2.02	2.52	0.67	2.36	0.34
Synoviocyte, donor2	11368-117I9	24.47	1.51	1.34	0.84	2.18	0.17
Synoviocyte, donor3	11440-118H9	15.86	0.45	0.45	0.22	0.89	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	80.40	2.14	2.50	2.86	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	0.00	3.96	3.96	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	54.65	2.55	0.69	0.46	1.62	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	28.24	0.43	0.79	2.65	0.93	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	49.87	1.16	1.16	2.71	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	42.38	0.00	1.72	5.73	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	48.47	2.21	1.11	0.25	1.97	0.25
Urethra, donor2	10319-105A4	12.59	0.00	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	41.71	1.06	0.53	1.59	2.66	0.00
Urothelial Cells, donor2	11600-120H7	36.85	1.20	1.60	1.60	2.80	0.00
Urothelial Cells, donor3	11681-122H7	35.53	2.06	0.92	1.38	1.83	0.23
Urothelial cells, donor0	11216-116B1	45.69	1.78	0.22	0.67	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	23.13	1.78	0.00	0.89	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	35.74	0.00	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	20.54	0.68	2.05	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.68	0.34	1.03	0.00	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.08	0.58	0.58	0.58	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	29.15	0.00	1.04	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.94	1.84	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	0.00	1.83	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	45.77	2.84	2.10	5.30	3.21	0.37
Wilms' tumor cell line:HFWT	10597-108E3	31.68	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	67.59	2.51	1.12	1.68	2.23	0.56
achilles tendon, donor2	10292-104G4	18.60	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	60.93	2.80	2.04	4.08	5.86	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.51	2.55	3.48	2.79	1.86	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	89.39	2.73	1.07	0.95	1.42	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	126.53	7.62	4.63	2.45	4.08	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	95.29	3.65	5.62	5.62	2.53	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	66.41	2.54	2.11	3.81	1.27	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	48.73	5.17	4.63	4.90	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	93.86	3.53	3.08	1.76	3.53	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	133.94	3.68	4.08	3.27	3.27	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	97.85	1.94	3.88	2.72	3.49	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	155.48	9.02	7.36	18.58	6.07	2.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	7.80	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.35	4.18	4.18	4.88	3.25	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	117.28	10.36	4.14	3.11	4.14	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	112.51	4.68	2.34	2.34	2.05	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	91.56	3.72	4.18	1.86	3.72	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	82.25	2.88	2.47	6.17	2.06	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	56.17	1.84	0.61	1.53	2.76	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	120.76	5.55	2.99	2.13	4.69	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	107.06	7.89	0.91	1.82	6.37	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	131.18	6.50	3.85	2.41	6.74	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	75.95	4.68	5.57	4.90	3.56	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	53.03	2.00	1.00	2.67	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	1.86	0.00	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	53.11	3.01	4.14	9.79	2.26	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.96	0.00	3.05	2.18	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	3.75	5.62	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	79.60	3.77	1.65	1.65	1.88	0.24
adipose tissue, adult, pool1	10010-101C1	27.77	1.24	0.93	0.31	0.78	0.16
adipose, donor1	10184-103D4	20.52	2.35	0.59	1.17	0.00	0.00
adipose, donor2	10185-103D5	29.20	0.00	2.03	0.00	0.41	1.22
adipose, donor3	10186-103D6	27.50	0.82	1.91	1.91	0.82	0.00
adipose, donor4	10187-103D7	35.54	0.87	4.33	4.33	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	93.75	4.58	2.21	3.63	2.68	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	0.00	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	100.05	2.53	1.47	1.07	2.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.95	1.43	2.14	0.71	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	44.98	0.70	0.93	1.39	1.85	0.23
amniotic membrane cells, donor2	12236-129G4	43.95	0.34	3.72	1.01	1.69	0.00
amniotic membrane cells, donor3	12237-129G5	25.63	0.59	1.77	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	17.79	1.19	0.00	0.00	0.00	2.37
amygdala, adult, donor10252	10151-102I7	22.51	0.81	0.00	0.81	0.41	0.61
amygdala, newborn, donor10223	10360-105E9	13.56	4.84	0.32	0.97	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	59.85	5.86	2.42	2.55	3.57	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	120.90	4.63	11.03	7.06	12.58	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.40	0.33	1.00	0.00	2.00	0.67
aorta, adult, pool1	10052-101G7	20.79	0.00	0.39	0.00	0.59	0.20
appendix, adult	10189-103D9	31.05	1.16	0.00	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	49.53	2.41	4.13	1.72	1.03	0.00
artery, adult	10190-103E1	19.02	2.72	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	50.56	1.16	1.88	1.16	1.16	0.14
b cell line:RPMI1788	10427-106D4	124.61	4.01	1.78	4.16	3.57	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.36	1.39	0.55	0.55	2.77	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	83.85	1.98	2.58	2.38	3.87	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	68.29	6.53	3.68	3.01	5.02	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	66.55	4.47	3.91	1.12	2.24	0.00
bladder, adult, pool1	10011-101C2	36.72	0.22	0.43	0.00	0.98	0.00
blood, adult, pool1	10053-101G8	22.15	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	26.55	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	26.99	1.35	3.37	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	14.35	3.08	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	16.82	1.22	0.67	0.45	0.22	0.00
brain, fetal, pool1	10085-102B4	16.03	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	24.45	0.66	2.97	0.66	1.65	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	55.05	4.12	5.87	1.62	6.12	0.12
breast, adult, donor1	10080-102A8	23.36	1.26	1.26	0.00	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	125.26	6.10	6.35	3.56	7.88	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.87	0.31	1.55	1.24	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.30	2.99	1.84	0.69	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	55.92	6.29	3.15	3.39	4.12	0.24
carcinoid cell line:NCI-H1770	10703-109H1	52.66	3.76	2.82	2.82	1.88	0.94
carcinoid cell line:NCI-H727	10735-110B6	53.16	1.31	2.95	1.42	2.41	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	49.44	1.27	0.32	1.90	1.90	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	35.93	1.33	0.53	0.27	0.80	0.53
caudate nucleus - adult, donor10196	10177-103C6	27.63	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.92	2.34	0.17	0.67	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	29.04	1.53	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	21.61	2.93	0.00	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	52.44	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.75	0.21	0.00	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	14.83	0.34	0.00	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	21.59	0.00	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	16.14	0.00	0.00	0.00	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	13.89	0.73	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	125.23	10.78	2.73	9.06	3.59	0.43
cervical cancer cell line:ME-180	10553-107I4	57.34	2.15	2.65	2.15	3.15	0.00
cervix, adult, pool1	10013-101C4	27.93	0.73	0.84	0.31	0.42	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	62.84	6.83	3.76	1.67	3.76	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	79.91	7.08	6.46	3.36	3.98	0.25
choriocarcinoma cell line:SCH	10785-110H2	57.79	7.02	2.46	2.46	3.82	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	64.99	8.78	5.22	8.30	1.90	0.24
chorionic membrane cells, donor1	12238-129G6	45.30	1.71	1.99	1.14	2.85	0.28
chorionic membrane cells, donor2	12239-129G7	44.25	1.79	2.59	0.99	1.99	0.30
chorionic membrane cells, donor3	12240-129G8	47.81	1.65	2.20	1.10	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	70.69	4.04	4.04	7.07	1.01	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	91.44	2.11	3.65	3.46	3.27	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.96	2.96	5.49	2.96	2.75	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	98.10	3.60	1.80	5.65	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	119.73	5.32	1.94	6.53	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	115.65	5.90	2.44	5.70	2.24	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	75.97	3.83	0.59	5.59	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	60.73	3.13	9.90	3.91	1.04	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	68.12	0.91	1.14	2.29	1.14	0.91
clear cell carcinoma cell line:TEN	10636-108I6	78.08	3.47	2.60	1.39	2.60	0.52
colon carcinoma cell line:CACO-2	10513-107D9	60.40	6.41	8.79	2.01	6.41	0.18
colon carcinoma cell line:COLO-320	10420-106C6	209.80	6.84	1.14	5.32	6.46	0.38
colon, adult, donor1	10082-102B1	54.74	0.00	0.00	0.00	4.76	0.00
colon, adult, pool1	10014-101C5	31.84	0.82	0.94	0.12	1.29	0.00
colon, fetal, donor1	10070-101I7	19.78	0.00	0.00	0.00	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	41.64	2.12	2.12	2.55	1.70	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.32	4.23	2.11	3.92	2.26	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	59.08	4.09	1.83	3.53	2.68	0.00
corpus callosum, adult, pool1	10042-101F6	42.79	0.66	0.77	0.22	1.22	0.00
cruciate ligament, donor2	10295-104G7	17.02	0.81	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.87	1.61	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	23.28	1.68	0.24	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.00	1.61	2.30	2.76	1.61	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	60.78	2.31	5.64	3.33	3.85	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.64	8.18	3.37	4.57	5.30	0.48
ductus deferens, adult	10196-103E7	32.39	1.50	2.49	0.00	2.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	0.00	0.00	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	0.00	2.21	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	34.03	0.99	0.58	0.41	1.16	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	50.85	10.22	6.88	17.77	1.78	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	65.06	7.02	3.15	5.16	2.01	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	40.08	3.08	0.00	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	52.07	3.33	0.61	1.51	1.21	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	43.84	5.87	1.85	2.16	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	47.28	1.31	1.31	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	69.05	4.36	10.39	5.36	5.70	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	60.53	5.44	2.36	3.81	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	42.94	1.29	2.41	0.80	2.09	1.77
epidermoid carcinoma cell line:A431	10426-106D3	76.81	1.89	4.89	1.67	5.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	106.80	4.18	4.07	4.95	7.26	0.11
epididymis, adult	10197-103E8	20.72	0.84	0.21	0.21	1.26	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.71	3.02	0.71	1.24	1.24	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	41.29	5.11	2.36	3.54	2.75	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	199.98	12.32	5.37	9.17	9.04	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	183.26	11.02	5.12	10.04	7.58	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	203.33	11.99	6.27	10.42	9.63	1.46
esophagus, adult, pool1	10015-101C6	29.31	1.06	1.06	0.32	0.64	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.11	2.00	2.38	1.88	1.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	19.32	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.66	0.00	0.25	0.25	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	65.78	3.08	2.95	2.31	4.49	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	71.23	2.85	2.37	2.14	1.90	0.71
frontal lobe, adult, pool1	10040-101F4	18.76	1.03	0.56	0.84	0.38	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	96.08	3.00	4.50	3.00	4.80	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	88.33	2.29	2.47	2.93	1.92	0.09
gall bladder, adult	10198-103E9	30.90	1.21	2.41	0.00	2.17	0.24
gamma delta positive T cells, donor1	11937-126A2	47.24	1.07	1.07	0.54	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	43.33	1.49	0.75	0.00	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.54	2.96	1.27	1.06	2.32	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	75.82	3.48	2.32	2.13	4.26	0.00
gastric cancer cell line:AZ521	10549-107H9	80.17	3.44	1.48	4.59	1.64	0.00
gastric cancer cell line:GSS	10560-108A2	118.98	4.58	0.92	0.92	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	53.23	2.74	11.19	3.43	2.74	0.46
giant cell carcinoma cell line:LU65	10487-107B1	49.91	13.08	1.03	4.02	0.57	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	52.62	1.12	0.28	0.70	1.96	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	48.14	2.99	4.24	1.50	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	43.07	3.48	0.84	1.27	1.69	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	42.55	3.65	1.12	1.12	1.26	0.00
glioblastoma cell line:T98G	10485-107A8	67.22	3.97	1.55	1.99	1.77	0.11
glioma cell line:GI-1	10413-106B8	46.86	4.69	3.51	0.29	3.51	0.59
globus pallidus - adult, donor10196	10175-103C4	18.22	2.92	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	33.44	0.49	0.73	0.24	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	16.43	0.00	0.00	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	28.78	1.07	1.60	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	0.32	0.32	0.64	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	32.14	2.75	9.18	5.51	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	43.44	1.37	7.77	3.20	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	32.20	3.22	4.51	4.51	0.00	0.00
hIPS, biol_rep1	14380-156B6	48.87	1.44	1.44	10.06	0.00	0.00
hIPS, biol_rep2	14381-156B7	32.92	4.12	2.06	4.12	0.00	0.00
hIPS, biol_rep3	14382-156B8	18.76	0.00	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	22.70	1.15	1.15	0.57	0.29	0.00
heart - mitral valve, adult	10205-103F7	21.53	0.90	0.30	0.60	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	19.87	0.26	0.00	0.26	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	49.96	0.83	1.67	0.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	54.69	3.06	10.00	3.06	3.47	1.63
heart, adult, diseased, donor1	10051-101G6	28.96	0.00	0.00	0.00	1.70	0.00
heart, adult, pool1	10016-101C7	22.54	0.00	0.00	0.00	0.69	0.00
heart, fetal, pool1	10046-101G1	26.08	0.62	0.41	0.00	0.82	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.63	0.62	0.93	0.93	4.63	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	1.19	8.32	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	67.40	14.03	14.81	7.96	9.50	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	71.37	9.35	17.36	11.77	7.77	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	72.56	9.90	17.38	10.81	10.21	0.71
hepatoma cell line:Li-7	10484-107A7	36.15	1.22	2.11	1.78	1.45	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	84.62	3.72	6.63	6.03	3.62	0.30
hippocampus - adult, donor10196	10169-103B7	19.87	0.95	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	23.68	0.41	1.02	0.20	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	19.42	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	15.86	0.35	0.00	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	70.19	4.88	4.88	4.27	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	51.05	2.95	7.07	4.71	1.77	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	56.36	4.06	4.06	2.54	3.30	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.32	2.26	2.26	0.00	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.57	0.26	2.32	0.00	0.77	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.14	1.52	1.90	0.38	0.38	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	35.33	1.17	0.88	0.29	0.88	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	35.11	1.29	1.51	0.86	0.86	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.20	2.50	1.25	1.25	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	39.07	1.42	2.60	0.95	3.08	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	33.59	0.64	1.93	0.96	1.61	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	38.38	1.35	2.69	0.00	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	46.01	3.13	7.98	3.13	1.56	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	42.25	1.47	6.88	2.46	1.47	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	37.53	7.85	8.73	7.85	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.98	0.76	1.72	0.38	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	33.14	2.18	0.87	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.99	0.50	0.50	1.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	32.78	0.38	2.07	0.38	0.94	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	40.92	1.36	1.36	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.28	0.00	1.57	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	30.37	0.49	1.96	0.65	0.49	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	25.55	0.29	1.45	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.60	1.79	2.39	0.30	1.49	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	46.00	3.33	5.54	3.51	2.40	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	50.78	1.71	5.71	2.28	1.71	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	62.88	4.08	5.72	6.53	1.63	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	33.10	0.70	1.41	0.70	1.76	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	36.11	1.27	1.58	0.00	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.34	1.21	2.12	2.42	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.23	1.03	1.55	0.00	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.21	1.33	0.66	0.00	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.58	1.03	1.80	0.00	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	37.32	0.26	2.05	2.05	1.02	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	42.40	0.76	0.00	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.64	1.68	0.67	0.67	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	57.72	4.83	6.76	5.31	2.66	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	50.81	3.12	5.35	7.58	1.34	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	64.88	2.44	4.88	3.41	2.44	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.59	0.92	1.22	0.92	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	9.76	0.00	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	29.78	2.32	1.99	1.32	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	49.80	1.09	1.64	0.00	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.98	2.53	1.81	1.09	1.09	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.06	0.71	1.42	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	33.41	1.19	1.19	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	34.67	0.81	2.44	0.95	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	34.75	0.54	2.16	0.81	0.81	0.81
immature langerhans cells, donor1	11904-125F5	13.08	0.24	0.73	0.24	0.48	0.00
immature langerhans cells, donor2	11905-125F6	9.51	1.58	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	25.55	1.80	0.85	0.66	0.66	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	89.42	6.83	4.55	5.53	10.73	0.00
kidney, adult, pool1	10017-101C8	44.76	0.90	1.20	0.20	0.80	0.50
kidney, fetal, pool1	10045-101F9	44.07	0.92	1.41	0.07	1.63	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.79	1.70	2.98	1.85	1.42	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.31	1.38	0.83	0.69	3.04	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.28	2.75	0.92	0.92	1.65	0.37
left atrium, adult, donor1	10079-102A7	17.44	2.18	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	13.65	0.00	0.00	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	36.39	0.82	1.37	0.55	2.74	0.27
leiomyoma cell line:10964C	10569-108B2	28.74	3.23	2.51	1.80	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	32.61	2.17	1.63	3.80	2.17	1.09
leiomyoma cell line:15425	10571-108B4	36.91	1.70	0.97	1.21	1.21	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	1.05	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	61.98	2.48	17.47	7.79	4.60	0.12
liposarcoma cell line:KMLS-1	10782-110G8	35.62	0.31	1.25	0.16	2.03	0.16
liposarcoma cell line:SW 872	10726-110A6	27.90	3.66	1.71	0.85	0.97	0.00
liver, adult, pool1	10018-101C9	115.71	8.27	6.00	1.94	3.89	0.16
liver, fetal, pool1	10086-102B5	31.04	4.70	1.88	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	17.21	0.58	0.15	1.46	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	24.55	1.11	0.00	1.66	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	24.55	0.00	0.28	0.85	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	13.04	3.36	0.42	0.00	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	42.49	3.46	2.49	0.97	3.04	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	86.18	6.89	0.69	1.38	4.83	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.65	0.66	3.82	1.32	1.98	0.00
lung, adult, pool1	10019-101D1	22.21	0.47	0.24	0.35	0.47	0.24
lung, fetal, donor1	10068-101I5	28.54	0.86	1.14	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	21.08	0.00	0.00	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	29.35	0.47	0.47	0.47	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	60.49	1.53	2.41	1.75	5.92	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	52.37	2.57	2.72	2.57	1.21	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	83.25	3.40	10.19	1.70	6.80	0.00
mature adipocyte, donor1	12231-129F8	23.53	0.44	0.89	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	23.66	0.42	0.42	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	23.71	0.47	0.00	0.00	0.47	0.00
mature adipocyte, donor4	12234-129G2	18.69	0.79	0.26	0.79	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	130.80	4.53	4.29	4.05	5.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	21.88	0.55	0.18	0.55	0.55	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	15.25	0.32	0.32	1.27	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	17.49	2.99	0.85	2.13	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	20.25	1.35	0.34	1.18	0.17	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	29.29	0.64	0.42	0.64	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	3.85	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	11.84	3.95	0.36	0.72	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	26.61	0.65	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	31.12	1.08	0.77	0.15	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	27.59	1.06	0.73	1.06	0.98	0.00
medulla oblongata, newborn, donor10223	10361-105F1	29.86	1.04	1.39	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	84.58	1.55	3.99	2.44	2.88	1.33
medulloblastoma cell line:ONS-76	10759-110E3	57.22	2.20	3.06	2.20	3.79	0.00
melanoma cell line:COLO 679	10514-107E1	51.46	1.87	1.87	1.29	3.59	0.43
melanoma cell line:G-361	10465-106H6	80.35	3.53	2.44	1.63	1.63	0.27
meningioma cell line:HKBMM	10691-109F7	35.28	1.81	1.27	1.63	1.45	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	57.28	2.64	4.41	2.64	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	50.81	1.56	3.37	2.33	3.11	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	54.78	2.15	1.84	1.84	1.53	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.18	1.27	1.64	0.55	0.73	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	35.61	3.31	2.48	1.24	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.30	2.25	0.84	0.98	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.43	1.54	1.73	0.96	0.96	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	44.42	2.78	3.47	0.00	2.78	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.07	2.23	1.54	1.54	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	28.64	3.57	0.69	1.04	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	37.93	2.25	1.46	1.72	0.53	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.27	2.43	1.76	1.76	0.95	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.76	1.71	1.42	0.85	1.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	1.32	0.99	0.99	1.32	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.55	0.97	2.08	1.11	1.11	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.10	2.09	1.05	2.09	2.44	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.97	1.22	0.00	0.61	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	26.24	1.80	1.08	1.08	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.79	0.83	0.41	0.41	0.52	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	25.76	1.60	0.68	0.68	1.82	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	32.73	2.94	2.52	2.52	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	31.08	1.49	2.69	1.34	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	28.53	1.58	1.14	1.75	0.44	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.03	1.10	0.37	0.37	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.89	1.72	1.14	0.86	1.14	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.47	0.42	1.26	0.42	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.71	1.83	3.20	0.91	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	30.18	1.02	0.77	0.51	1.02	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.81	2.88	0.79	0.79	1.31	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	35.43	2.46	0.92	0.92	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.65	1.65	2.12	1.41	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	27.41	1.69	3.05	2.03	2.37	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.87	3.14	2.36	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.73	0.93	0.46	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	40.67	1.73	2.02	2.02	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.69	1.78	0.89	0.67	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.81	1.92	2.16	1.20	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	31.53	0.73	0.73	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.15	1.34	2.35	0.00	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.02	1.23	1.23	1.64	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	32.65	3.01	1.29	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	16.41	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.31	1.62	2.92	0.97	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	1.45	1.45	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	33.58	2.13	1.07	2.67	2.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	2.45	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	30.32	1.55	1.55	0.39	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	1.99	1.99	1.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	1.78	1.78	1.19	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	3.66	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	2.53	3.17	0.63	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	2.07	1.03	1.03	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	4.30	4.30	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	33.01	5.30	3.26	2.04	2.85	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	35.75	3.18	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.01	0.59	3.54	0.59	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.55	1.25	2.18	0.31	2.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	1.34	8.02	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	43.76	0.00	2.37	1.18	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	59.06	0.00	0.00	5.14	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	51.63	4.82	0.69	2.07	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	41.56	4.95	0.49	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	39.25	1.12	2.24	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	41.34	4.45	0.64	0.00	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	54.00	2.01	0.40	1.21	1.61	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	58.88	2.18	0.00	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	62.09	1.27	1.27	0.00	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	0.61	0.61	0.00	3.03	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	3.29	1.65	0.00	0.82	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.37	2.18	1.39	0.60	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.28	1.62	0.65	0.65	1.95	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	0.00	0.00	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.93	0.00	0.00	0.00	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	73.71	3.31	0.71	2.36	1.89	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.81	1.16	1.62	2.09	4.17	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	0.00	17.09	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.39	2.47	3.60	3.70	1.23	0.62
mesothelioma cell line:Mero-25	10850-111F4	61.96	4.77	2.95	9.53	2.72	1.59
mesothelioma cell line:Mero-41	10851-111F5	74.81	4.16	0.98	4.16	2.69	0.98
mesothelioma cell line:Mero-48a	10852-111F6	50.49	3.10	0.89	1.77	1.33	0.89
mesothelioma cell line:Mero-82	10853-111F7	29.96	2.10	2.37	1.05	2.10	0.53
mesothelioma cell line:Mero-83	10854-111F8	58.39	1.87	1.70	2.21	1.53	0.34
mesothelioma cell line:Mero-84	10855-111F9	44.49	3.03	3.03	1.77	2.27	0.76
mesothelioma cell line:Mero-95	10856-111G1	44.72	3.52	2.48	1.66	1.24	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	25.68	2.48	0.50	3.15	1.82	0.33
mesothelioma cell line:NCI-H226	10846-111E9	39.46	2.53	2.90	4.71	2.35	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	61.67	4.44	0.34	2.73	2.05	0.68
mesothelioma cell line:NCI-H28	10845-111E8	60.56	2.04	1.27	0.76	2.04	0.00
mesothelioma cell line:No36	10857-111G2	62.96	2.28	0.65	4.24	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	53.38	2.71	1.90	3.52	2.44	0.54
migratory langerhans cells, donor1	11901-125F2	8.83	0.19	0.19	0.00	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	8.43	0.00	0.00	0.00	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	9.87	0.00	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.14	2.29	0.65	1.31	1.96	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	38.36	0.85	11.87	0.85	1.48	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.86	0.23	2.76	0.46	1.61	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.93	0.00	0.76	0.76	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	203.09	8.87	7.02	7.58	8.50	3.51
myeloma cell line:PCM6	10474-106I6	79.66	2.17	7.51	4.15	10.48	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	0.51	1.52	1.52	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	55.70	1.57	2.55	1.18	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	47.91	1.89	0.89	2.23	1.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	43.17	2.06	0.88	1.76	1.03	0.29
nasal epithelial cells, donor2	12227-129F4	34.78	0.55	1.10	1.10	3.31	0.00
neuroblastoma cell line:CHP-134	10508-107D4	96.17	10.12	9.43	7.13	3.68	0.92
neuroblastoma cell line:NB-1	10539-107G8	74.83	1.68	3.37	0.19	1.68	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	95.11	2.32	3.37	4.01	1.90	0.63
neuroblastoma cell line:NH-12	10555-107I6	120.57	6.89	4.10	3.35	4.10	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.57	1.19	2.14	0.00	1.42	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.17	1.90	0.95	0.79	0.95	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	100.63	5.43	5.64	2.21	4.23	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	74.38	1.91	0.64	0.64	6.36	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	27.42	0.80	2.93	0.53	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	82.19	2.37	1.35	0.00	1.35	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	26.42	0.00	4.00	0.80	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.98	3.53	2.89	1.60	0.96	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.01	1.31	0.79	2.10	2.63	1.31
nucleus accumbens, adult, pool1	10037-101F1	27.65	1.59	0.47	0.56	0.66	0.00
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	27.64	2.42	0.27	0.00	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	16.38	5.10	0.00	1.09	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	15.22	0.26	0.00	0.79	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	25.32	0.00	0.86	0.00	0.00	0.86
occipital pole, adult, pool1	10036-101E9	25.23	1.02	0.87	0.79	0.39	0.08
olfactory region, adult	10195-103E6	16.05	0.76	0.19	0.96	0.19	0.00
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	89.65	15.15	8.32	10.94	6.04	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	130.65	5.63	3.30	1.24	4.95	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	44.02	1.52	3.05	1.69	1.19	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.64	1.27	5.66	1.73	1.73	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	25.28	1.76	0.88	0.88	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	41.11	0.00	0.00	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	62.35	1.70	5.30	0.85	2.76	0.42
ovary, adult, pool1	10020-101D2	27.78	0.00	0.26	0.17	1.14	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	29.70	0.73	1.65	1.10	2.20	0.18
pancreas, adult, donor1	10049-101G4	68.67	1.88	1.88	0.00	8.47	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.99	2.24	2.52	6.99	3.63	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	59.45	4.43	0.68	4.26	0.68	3.41
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	38.25	1.32	0.66	0.66	0.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	23.98	0.73	0.46	0.55	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	16.88	0.73	0.73	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	0.94	0.00	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	15.39	0.86	0.00	1.14	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	20.80	1.76	0.53	1.06	0.62	0.00
parietal lobe, fetal, donor1	10072-101I9	14.55	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.09	2.24	0.00	1.87	0.00	0.00
parotid gland, adult	10199-103F1	47.48	4.32	3.08	0.62	7.40	0.00
penis, adult	10200-103F2	24.71	1.07	1.61	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.42	1.30	0.00	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.40	1.75	2.33	1.31	4.08	0.00
pineal gland - adult, donor10196	10179-103C8	27.74	0.65	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	36.12	1.18	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	21.95	1.25	1.25	0.00	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	35.41	0.00	4.05	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	51.60	2.08	2.08	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	34.90	0.00	3.40	0.00	1.70	0.00
placenta, adult, pool1	10021-101D3	52.78	2.04	1.40	0.54	1.51	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	57.61	2.25	0.66	2.12	1.32	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	43.73	0.47	1.25	0.31	1.56	0.62
pons, adult, pool1	10033-101E6	23.58	1.20	0.52	1.20	0.43	0.00
postcentral gyrus, adult, pool1	10032-101E5	25.28	1.22	0.44	0.87	0.70	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	11.74	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	67.88	4.66	2.18	6.26	2.91	0.87
prostate cancer cell line:PC-3	10439-106E7	68.79	2.72	2.72	2.36	3.63	0.00
prostate, adult, pool1	10022-101D4	32.56	0.54	0.82	0.00	0.45	0.00
putamen, adult, donor10196	10176-103C5	23.61	1.18	0.24	0.24	0.00	0.24
putamen, adult, donor10252	10152-102I8	33.33	3.92	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	2.19	0.00	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	18.85	0.48	0.24	0.24	0.24	0.00
putamen, newborn, donor10223	10365-105F5	11.24	3.00	0.00	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	56.44	0.58	3.78	1.45	1.16	0.00
rectum, fetal, donor1	10067-101I4	29.21	0.00	0.00	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	54.27	3.18	0.85	2.33	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.87	2.49	0.41	1.66	0.41	0.83
retina, adult, pool1	10030-101E3	35.78	0.30	0.60	0.30	0.80	0.00
retinoblastoma cell line:Y79	10475-106I7	90.67	3.90	2.60	4.42	2.34	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.61	0.98	1.72	2.70	1.11	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	52.87	1.41	3.09	0.56	1.97	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	0.76	1.52	0.76	1.52	0.00
salivary acinar cells, donor1	11771-123I7	35.45	2.27	1.78	1.78	2.10	0.16
salivary acinar cells, donor2	11772-123I8	32.08	0.96	0.96	1.24	1.51	0.00
salivary acinar cells, donor3	11773-123I9	15.23	0.00	0.00	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	52.62	3.43	4.00	0.00	2.29	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.69	4.97	0.34	2.45	0.51	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.27	5.05	0.71	1.41	1.18	0.12
seminal vesicle, adult	10201-103F3	28.04	0.53	3.17	0.00	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	52.96	2.43	3.89	0.49	3.40	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	36.24	2.52	1.01	1.26	1.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	53.19	0.00	3.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.56	3.22	4.43	1.07	3.22	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	86.87	2.76	1.55	2.43	1.66	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	102.96	3.23	3.74	3.10	3.61	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	15.61	1.42	0.00	0.00	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	23.27	1.92	0.12	0.24	1.08	0.00
skeletal muscle, fetal, donor1	10066-101I3	35.18	3.02	1.01	1.01	2.01	3.02
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	28.41	0.00	0.00	0.63	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.37	3.00	0.33	1.67	3.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	42.87	2.84	5.04	1.89	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	67.08	3.28	0.77	0.96	1.35	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	80.11	1.48	6.92	2.14	2.97	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	327.01	6.27	1.61	2.25	4.18	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.17	4.36	7.63	1.96	1.31	0.44
small intestine, adult, pool1	10024-101D6	45.63	0.84	0.96	0.12	0.96	0.24
small intestine, fetal, donor1	10064-101I1	48.16	1.23	3.93	0.98	1.72	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	70.27	1.54	2.56	1.03	0.51	4.10
smooth muscle, adult, pool1	10048-101G3	26.10	0.26	1.03	0.26	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	30.29	1.34	1.61	1.07	1.88	0.00
spinal cord - adult, donor10196	10181-103D1	15.37	0.23	0.69	0.69	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	24.84	1.18	0.39	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	20.06	0.69	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	38.42	0.00	1.22	1.22	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	30.77	2.76	0.00	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.47	0.75	1.05	1.05	2.54	0.15
spleen, adult, pool1	10025-101D7	28.30	0.66	0.55	0.55	0.88	0.22
spleen, fetal, pool1	10044-101F8	33.21	1.43	1.75	0.40	1.11	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	50.51	3.31	2.07	3.21	3.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	52.22	1.90	4.18	2.66	5.89	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	82.47	6.64	16.77	6.29	5.24	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	78.19	3.13	10.56	5.08	3.91	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	76.88	15.76	10.36	11.37	3.71	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	183.00	2.97	17.79	5.51	12.28	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	59.23	2.54	2.12	1.69	5.08	0.00
stomach, fetal, donor1	10062-101H8	23.50	0.00	3.20	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	37.60	4.56	2.28	1.14	4.56	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	31.16	2.08	0.62	0.00	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	20.69	0.00	1.03	0.52	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	19.08	0.00	0.00	0.00	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.31	2.06	2.29	3.44	2.75	0.23
temporal lobe, adult, pool1	10031-101E4	25.86	1.10	0.42	1.61	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.08	0.00	1.42	0.71	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.05	0.88	0.44	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	48.87	2.44	1.05	0.70	2.09	0.35
tenocyte, donor2	11765-123I1	27.47	1.91	1.14	0.38	0.76	0.38
tenocyte, donor3	11768-123I4	40.03	2.59	2.59	0.74	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	131.21	4.25	12.07	14.45	5.44	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	37.46	0.46	1.54	0.92	1.70	0.15
teratocarcinoma cell line:PA-1	10807-111A6	45.41	2.01	3.25	2.01	1.24	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	40.37	0.63	3.55	2.54	3.17	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	193.62	4.92	10.21	9.08	2.27	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	46.35	1.85	3.60	2.62	0.55	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	48.20	1.95	1.95	4.23	2.93	1.30
testis, adult, pool1	10026-101D8	51.65	1.40	3.97	0.97	1.61	0.54
testis, adult, pool2	10096-102C6	71.27	1.80	5.41	0.45	2.26	0.00
thalamus - adult, donor10196	10168-103B6	18.77	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	30.32	1.09	0.31	0.00	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.09	0.66	0.00	0.00	0.49	0.16
thalamus, newborn, donor10223	10366-105F6	12.08	2.30	1.15	4.03	0.00	0.58
throat, adult	10209-103G2	25.72	0.00	0.75	0.25	0.25	0.50
throat, fetal, donor1	10061-101H7	20.11	0.61	0.30	0.00	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	56.84	2.58	7.35	1.39	3.38	0.40
thymus, adult, pool1	10027-101D9	32.01	1.49	0.89	0.20	1.09	0.60
thymus, fetal, pool1	10043-101F7	32.21	0.62	0.52	0.42	1.14	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	40.15	1.46	0.93	1.99	1.60	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	73.76	4.89	0.84	1.26	2.24	0.42
thyroid, adult, pool1	10028-101E1	39.75	1.31	0.56	0.00	1.40	0.37
thyroid, fetal, donor1	10060-101H6	27.95	0.26	1.58	0.00	1.58	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	23.72	2.56	1.63	2.33	0.93	0.93
tongue, fetal, donor1	10059-101H5	26.80	0.39	0.79	0.79	0.79	0.39
tonsil, adult, pool1	10047-101G2	48.89	1.70	1.90	0.70	1.30	0.10
trachea, adult, pool1	10029-101E2	44.50	0.90	1.15	0.49	1.72	0.16
trachea, fetal, donor1	10058-101H4	27.31	2.31	0.77	0.38	1.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.78	2.48	1.77	2.48	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	47.92	2.53	1.93	1.32	1.62	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	86.18	4.23	2.66	2.51	2.51	0.31
tridermal teratoma cell line:HGRT	10694-109G1	15.22	0.00	0.00	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	38.52	1.27	2.03	0.68	1.02	0.08
umbilical cord, fetal, donor1	10057-101H3	45.90	0.00	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	25.94	0.68	0.34	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	19.97	1.54	0.00	0.00	1.02	0.51
vagina, adult	10204-103F6	31.02	0.00	1.29	0.00	0.65	0.65
vein, adult	10191-103E2	29.81	1.75	0.66	0.22	1.75	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	34.18	0.53	0.80	0.80	0.27	0.53